A30561 Search Results


agonist ky19382  (MedChemExpress)
93
MedChemExpress agonist ky19382
ALA-PDT-mediated sebosuppressive effects on XL-i-20 sebocytes were reversed by Wnt/β-catenin pathway activation. ( A ) Relative protein expression of β-catenin, FAS, and SREBP1 with or without <t>KY19382</t> pre-treatment and different doses of ALA-PDT. GAPDH was used as a control. ( B ) The relative expression levels of β-catenin, FAS, and SREBP1 were semi-quantitatively analyzed. Similar results were observed in three independent experiments. ( C ) Nile red staining and BODIPY 493/503 staining of XL-i-20 sebocytes 24 h after ALA-PDT with or without KY19382 pre-treatment. ( D-E ) Semiquantitative analysis of lipid droplets per cell in 5 C. KY19382 is an activator of Wnt/β-catenin, and PDT1 and PDT2 means ALA-PDT with light doses of 5 J/cm 2 and 10 J/cm 2 , respectively. KY + PDT1 and KY + PDT2 indicate the combination of KY19382 and different doses of ALA-PDT. * indicates p < 0.05, ** indicates p < 0.01, n = 3
Agonist Ky19382, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/agonist ky19382/product/MedChemExpress
Average 93 stars, based on 1 article reviews
agonist ky19382 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
association for assessment and accreditation of animal care (aaalac) accredited facilities  (AAALAC International Inc)
90
AAALAC International Inc association for assessment and accreditation of animal care (aaalac) accredited facilities
ALA-PDT-mediated sebosuppressive effects on XL-i-20 sebocytes were reversed by Wnt/β-catenin pathway activation. ( A ) Relative protein expression of β-catenin, FAS, and SREBP1 with or without <t>KY19382</t> pre-treatment and different doses of ALA-PDT. GAPDH was used as a control. ( B ) The relative expression levels of β-catenin, FAS, and SREBP1 were semi-quantitatively analyzed. Similar results were observed in three independent experiments. ( C ) Nile red staining and BODIPY 493/503 staining of XL-i-20 sebocytes 24 h after ALA-PDT with or without KY19382 pre-treatment. ( D-E ) Semiquantitative analysis of lipid droplets per cell in 5 C. KY19382 is an activator of Wnt/β-catenin, and PDT1 and PDT2 means ALA-PDT with light doses of 5 J/cm 2 and 10 J/cm 2 , respectively. KY + PDT1 and KY + PDT2 indicate the combination of KY19382 and different doses of ALA-PDT. * indicates p < 0.05, ** indicates p < 0.01, n = 3
Association For Assessment And Accreditation Of Animal Care (Aaalac) Accredited Facilities, supplied by AAALAC International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/association for assessment and accreditation of animal care (aaalac) accredited facilities/product/AAALAC International Inc
Average 90 stars, based on 1 article reviews
association for assessment and accreditation of animal care (aaalac) accredited facilities - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
anti-grin2b #a3056  (ABclonal Biotechnology)
90
ABclonal Biotechnology anti-grin2b #a3056
ALA-PDT-mediated sebosuppressive effects on XL-i-20 sebocytes were reversed by Wnt/β-catenin pathway activation. ( A ) Relative protein expression of β-catenin, FAS, and SREBP1 with or without <t>KY19382</t> pre-treatment and different doses of ALA-PDT. GAPDH was used as a control. ( B ) The relative expression levels of β-catenin, FAS, and SREBP1 were semi-quantitatively analyzed. Similar results were observed in three independent experiments. ( C ) Nile red staining and BODIPY 493/503 staining of XL-i-20 sebocytes 24 h after ALA-PDT with or without KY19382 pre-treatment. ( D-E ) Semiquantitative analysis of lipid droplets per cell in 5 C. KY19382 is an activator of Wnt/β-catenin, and PDT1 and PDT2 means ALA-PDT with light doses of 5 J/cm 2 and 10 J/cm 2 , respectively. KY + PDT1 and KY + PDT2 indicate the combination of KY19382 and different doses of ALA-PDT. * indicates p < 0.05, ** indicates p < 0.01, n = 3
Anti Grin2b #A3056, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-grin2b #a3056/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
anti-grin2b #a3056 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
digital camera sony a3056  (Sony)
90
Sony digital camera sony a3056
ALA-PDT-mediated sebosuppressive effects on XL-i-20 sebocytes were reversed by Wnt/β-catenin pathway activation. ( A ) Relative protein expression of β-catenin, FAS, and SREBP1 with or without <t>KY19382</t> pre-treatment and different doses of ALA-PDT. GAPDH was used as a control. ( B ) The relative expression levels of β-catenin, FAS, and SREBP1 were semi-quantitatively analyzed. Similar results were observed in three independent experiments. ( C ) Nile red staining and BODIPY 493/503 staining of XL-i-20 sebocytes 24 h after ALA-PDT with or without KY19382 pre-treatment. ( D-E ) Semiquantitative analysis of lipid droplets per cell in 5 C. KY19382 is an activator of Wnt/β-catenin, and PDT1 and PDT2 means ALA-PDT with light doses of 5 J/cm 2 and 10 J/cm 2 , respectively. KY + PDT1 and KY + PDT2 indicate the combination of KY19382 and different doses of ALA-PDT. * indicates p < 0.05, ** indicates p < 0.01, n = 3
Digital Camera Sony A3056, supplied by Sony, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/digital camera sony a3056/product/Sony
Average 90 stars, based on 1 article reviews
digital camera sony a3056 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
rabbit anti-nr2b  (ABclonal Biotechnology)
90
ABclonal Biotechnology rabbit anti-nr2b
Minocycline inhibits the upregulation of NMDAR induced by MW exposure. a The schedule of experiment design. b – c The protein expression of NR2A and <t>NR2B</t> in mPFC of mice. Data are presented as mean ± SEM (n = 8). *P < 0.05, **P < 0.01, ***P < 0.001 (two-way ANOVA and Tukey’s multiple comparisons test)
Rabbit Anti Nr2b, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-nr2b/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
rabbit anti-nr2b - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
gapdh antibody  (ABclonal Biotechnology)
90
ABclonal Biotechnology gapdh antibody
Minocycline inhibits the upregulation of NMDAR induced by MW exposure. a The schedule of experiment design. b – c The protein expression of NR2A and <t>NR2B</t> in mPFC of mice. Data are presented as mean ± SEM (n = 8). *P < 0.05, **P < 0.01, ***P < 0.001 (two-way ANOVA and Tukey’s multiple comparisons test)
Gapdh Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gapdh antibody/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
gapdh antibody - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
glun2b a3056  (ABclonal Biotechnology)
90
ABclonal Biotechnology glun2b a3056
Minocycline inhibits the upregulation of NMDAR induced by MW exposure. a The schedule of experiment design. b – c The protein expression of NR2A and <t>NR2B</t> in mPFC of mice. Data are presented as mean ± SEM (n = 8). *P < 0.05, **P < 0.01, ***P < 0.001 (two-way ANOVA and Tukey’s multiple comparisons test)
Glun2b A3056, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/glun2b a3056/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
glun2b a3056 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
bdnf antibody anti-mouse a18129  (ABclonal Biotechnology)
90
ABclonal Biotechnology bdnf antibody anti-mouse a18129
Minocycline inhibits the upregulation of NMDAR induced by MW exposure. a The schedule of experiment design. b – c The protein expression of NR2A and <t>NR2B</t> in mPFC of mice. Data are presented as mean ± SEM (n = 8). *P < 0.05, **P < 0.01, ***P < 0.001 (two-way ANOVA and Tukey’s multiple comparisons test)
Bdnf Antibody Anti Mouse A18129, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bdnf antibody anti-mouse a18129/product/ABclonal Biotechnology
Average 90 stars, based on 1 article reviews
bdnf antibody anti-mouse a18129 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
rabbit anti-nmdar2b antibody  (Beijing Solarbio Science)
90
Beijing Solarbio Science rabbit anti-nmdar2b antibody
Minocycline inhibits the upregulation of NMDAR induced by MW exposure. a The schedule of experiment design. b – c The protein expression of NR2A and <t>NR2B</t> in mPFC of mice. Data are presented as mean ± SEM (n = 8). *P < 0.05, **P < 0.01, ***P < 0.001 (two-way ANOVA and Tukey’s multiple comparisons test)
Rabbit Anti Nmdar2b Antibody, supplied by Beijing Solarbio Science, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-nmdar2b antibody/product/Beijing Solarbio Science
Average 90 stars, based on 1 article reviews
rabbit anti-nmdar2b antibody - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
apol2 antibody  (Bethyl)
N/A
Rabbit anti APOL2 Antibody Affinity Purified
   Buy from Supplier
adrenosterone d10  (Toronto Research Chemicals)
N/A
Adrenosterone d10 major
   Buy from Supplier
2-amino-6-(3-aminophenyl)-3,4-dihydropyrimidin-4-one  (Biosynth Carbosynth)
N/A
   Buy from Supplier

Image Search Results


ALA-PDT-mediated sebosuppressive effects on XL-i-20 sebocytes were reversed by Wnt/β-catenin pathway activation. ( A ) Relative protein expression of β-catenin, FAS, and SREBP1 with or without KY19382 pre-treatment and different doses of ALA-PDT. GAPDH was used as a control. ( B ) The relative expression levels of β-catenin, FAS, and SREBP1 were semi-quantitatively analyzed. Similar results were observed in three independent experiments. ( C ) Nile red staining and BODIPY 493/503 staining of XL-i-20 sebocytes 24 h after ALA-PDT with or without KY19382 pre-treatment. ( D-E ) Semiquantitative analysis of lipid droplets per cell in 5 C. KY19382 is an activator of Wnt/β-catenin, and PDT1 and PDT2 means ALA-PDT with light doses of 5 J/cm 2 and 10 J/cm 2 , respectively. KY + PDT1 and KY + PDT2 indicate the combination of KY19382 and different doses of ALA-PDT. * indicates p < 0.05, ** indicates p < 0.01, n = 3

Journal: Molecular Medicine

Article Title: Mechanistic insights into 5-aminolevulinic acid photodynamic therapy for acne vulgaris: targeting lipogenesis via the OLR1-Wnt/β-catenin pathway

doi: 10.1186/s10020-025-01104-w

Figure Lengend Snippet: ALA-PDT-mediated sebosuppressive effects on XL-i-20 sebocytes were reversed by Wnt/β-catenin pathway activation. ( A ) Relative protein expression of β-catenin, FAS, and SREBP1 with or without KY19382 pre-treatment and different doses of ALA-PDT. GAPDH was used as a control. ( B ) The relative expression levels of β-catenin, FAS, and SREBP1 were semi-quantitatively analyzed. Similar results were observed in three independent experiments. ( C ) Nile red staining and BODIPY 493/503 staining of XL-i-20 sebocytes 24 h after ALA-PDT with or without KY19382 pre-treatment. ( D-E ) Semiquantitative analysis of lipid droplets per cell in 5 C. KY19382 is an activator of Wnt/β-catenin, and PDT1 and PDT2 means ALA-PDT with light doses of 5 J/cm 2 and 10 J/cm 2 , respectively. KY + PDT1 and KY + PDT2 indicate the combination of KY19382 and different doses of ALA-PDT. * indicates p < 0.05, ** indicates p < 0.01, n = 3

Article Snippet: The β-catenin inhibitor XAV-939 and the specific agonist KY19382 were purchased from Med Chem Express (NJ, USA).

Techniques: Activation Assay, Expressing, Control, Staining

Minocycline inhibits the upregulation of NMDAR induced by MW exposure. a The schedule of experiment design. b – c The protein expression of NR2A and NR2B in mPFC of mice. Data are presented as mean ± SEM (n = 8). *P < 0.05, **P < 0.01, ***P < 0.001 (two-way ANOVA and Tukey’s multiple comparisons test)

Journal: Cell & Bioscience

Article Title: Acute exposure of microwave impairs attention process by activating microglial inflammation

doi: 10.1186/s13578-023-01162-9

Figure Lengend Snippet: Minocycline inhibits the upregulation of NMDAR induced by MW exposure. a The schedule of experiment design. b – c The protein expression of NR2A and NR2B in mPFC of mice. Data are presented as mean ± SEM (n = 8). *P < 0.05, **P < 0.01, ***P < 0.001 (two-way ANOVA and Tukey’s multiple comparisons test)

Article Snippet: The primary antibodies for Western blot analysis were listed as follows: rabbit anti-CD36 (1:1000, ABclonal, Cat# A5792, RRID: AB_2766544), rabbit anti-PPT1 (1:1000, ABclonal, Cat# 14769, RRID: AB_2761645), rabbit anti-LRP1 (1:1000, ABclonal, Cat# A0633, RRID: AB_2861470), goat anti-Iba-1 (1:3000, Abcam, Cat# ab5076, RRID: AB_2224402), mouse anti-TNF-α (1:3000, Abcam, Cat# ab1793, RRID: AB_302615), mouse anti-Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (1:5000, Abcam, Cat# ab8245, RRID: AB_2107448), rabbit anti-CD68 (1:3000, ABclonal, Cat# A20803, RRID: AB_2940793, Wuhan, China), rabbit anti-NR2A (1:3000, ABclonal, Cat# A19089, RRID: AB_2862581), and rabbit anti-NR2B (1:3000, ABclonal, Cat# A3056, RRID: AB_2764860).

Techniques: Expressing